ArticleCommunity mental health journal2018
Oxford House Residents' Attitudes Toward Medication Assisted Treatment Use in Fellow Residents.
Article in Community mental health journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Risk and protective factors for relapse after residential substance use treatment: a systematic review and meta-analysis.BMC psychiatry · 2026Pooled it
- Recovery housing and on-the-ground research priorities: a scoping study through the lens of community based participatory research.Frontiers in public health · 2025Pooled it
- Would we, could we? Measuring attitudinal and capacity barriers to supporting recovery housing residents on medication for opioid use disorder.Journal of substance use and addiction treatment · 2026Article
- Policies and practices addressing medication and substance use in recovery housing: findings from a nationally representative survey.The American journal of drug and alcohol abuse · 2026Article
- "Now that we've opened the door": challenges recovery home directors face when housing residents receiving medication for opioid use disorder.Substance abuse treatment, prevention, and policy · 2025Article
- Social networks illustrate harm reduction mechanisms in recovery homes.Journal of prevention & intervention in the community · 2025Article
- A roadmap for maximizing the use and effectiveness of recovery housing for individuals prescribed medications for opiate use disorders.Frontiers in public health · 2025Article
- Sustaining substance use recovery housing for people taking medications for opioid use disorder: diverse funding, strategic partnerships, and charging rent.Frontiers in public health · 2025Article
- Article
- U.S. Healthcare Workers' Perspective of Outpatient Provision of Methadone: A Scoping Review.Substance use & addiction journal · 2024Article
- The effect of a pilot brief educational intervention on preferences regarding treatments for opioid use disorder.Drug and alcohol dependence reports · 2024Article
- Effects of strength of relationship ties in recovery homes: A conundrum.The International journal on drug policy · 2024Article
- Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers.The American journal of drug and alcohol abuse · 2023Article
- "Knowing or not knowing": Living as harm reductionists in Twelve Step recovery.Journal of substance use and addiction treatment · 2023Article
- Association of facility characteristics and substance use disorder outcomes at discharge from residential treatment.Journal of substance abuse treatment · 2022Article
- The "black box" of treatment: Patients' perspective on what works in opioid maintenance treatment for opioid dependence.Substance abuse treatment, prevention, and policy · 2021Article
- Medications for Opioid Use Disorder Utilization Among Oxford House Residents.Community mental health journal · 2020Article
- Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.The American journal of drug and alcohol abuse · 2020Article
- Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.JAMA network open · 2020Article
- Medication assisted therapy and recovery homes.Journal of prevention & intervention in the communityArticle
Corrections and comments
- Erratum issued
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Methadone and buprenorphine/naloxone are medication assisted treatment (MAT) options for treating opioid use disorder, yet attitudes regarding their use within abstinence-based recovery homes have not been assessed. The present investigation examined attitudes regarding MAT utilization among residents living in Oxford Houses. This cross-sectional investigation compared residents (n = 87) receiving MAT whose recent drug use involved opioids, and two groups not receiving MATs; those who had used opioids and those who had used substances other than opioids. The vast majority of residents were not receiving MAT, yet 32% reported MAT histories. Negative attitudes regarding MAT were observed among residents who were not receiving MAT. Those presently receiving MAT reported mixed attitudes regarding the use of methadone and buprenorphine/naloxone, and two of these residents reported they had never been prescribed MAT. Findings suggest that abstinence-based recovery homes such as Oxford Houses may not be optimal resources for persons receiving MATs.
Indexed as
Identifiers
29302767What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.